Cambrex names Shlomo Yanai chairman

– – Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed chairman of US drug development company Cambrex Corporation (NYSE: CBM). He succeeds More...

Teva Sells Andromeda Diabetes Treatment Stake For $72 Million

– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1 Diabetes. – Clal Biotechnology Industries Ltd. (TASE: CBI) More...

Former IDF General Sues Teva For $5.5 Million

– Brig-Gen (res.) Gil Hirsch claims he is owed the money for mediating Teva’s acquisition of Cephalon. Brigadier General (res.) Gil Hirsch filed a suit against Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; More...